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The degradation of exogenous sphingomyelin was investigated in cultured fibroblasts from normal 
subjects and subjects with familial hypercholesterolemia, either in whole medium or in lipoprotein- 
deficient medium. When introduced in whole medium, sphingomyelin degradation was significantly 
decreased (about 1 .5-fold) in heterozygotes, and dramatically (about 4-fold) in homozygotes from familial 
hypercholesterolemia. Sphingomyelinase activity, measured in vitro by conventional methods, was not 
altered in fibroblasts from familial hypercholesterolemia. The sphingomyelin uptake was notably lower in 
familial hypercholesterolemia than in controls. The decrease in exogenous sphingomyelin degradation was 
also found in lipoprotein-deficient medium, suggesting that it is not related to the low density lipoprotein 
receptor impairment which exists in familial hypercholesterolemia. These results are discussed in relation 
to sphingomyelin a d cholesterol metabolism, and possible abnormalities of the cell membrane in familial 
hypercholesterolemia are suggested. 
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1. INTRODUCTION 
Several papers have pointed out a close relation- 
ship between sphingomyelin and cholesterol 
metabolisms. Authors in [l] described an inhibi- 
tion of LDL internalization in fibroblasts treated 
with positively charged liposomes containing SM. 
We previously reported [2] alterations of 
cholesterol metabolism in fibroblasts from patients 
with Niemann-Pick disease, a genetic disorder 
characterized by SM accumulation, and in vitro [3] 
and in situ [4] inhibition of SM degradation by 
sterols. All these results suggest that cholesterol 
and SM, closely related in membranes, also have 
closely related metabolisms, and probably some 
common regulatory mechanisms. This hypothesis 
is especially supported by the results in [5], 
demonstrating an inhibition of SM biosynthesis by 
LDL in normal fibroblasts. This suggests a role of 
LDL in SM metabolism, and it may be supposed 
that the lack of LDL receptors which exists in 
familial hypercholesterolemia (FH) could result in 
alterations of SM metabolism. We thus in- 
vestigated SM catabolism in FH fibroblasts. We 
report here a marked decrease of the in situ 
degradation of SM in FH fibroblasts as compared 
to normal fibroblasts. This phenomenon was also 
found in LDL-deficient medium, suggesting that it 
is not related to the LDL receptor deficiency, but 
rather to an as yet unknown abnormality of FH 
cells. 
2. MATERIALS AND METHODS 
2.1. Ceil culture 
Abbreviations: LDL. low density lipoprotein; SM, Control fibroblasts were obtained from skin 
sphingomyelin; FH, familial hypercholesterolemia; biopsy, and FH (heterozygotes and homozygotes) 
WM, whole medium; LDM, lipoprotein-deficient from the Mutant Genetic Cell Repository, 
medium Camden, USA. Cells were cultivated in 60-mm 
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petri dishes containing Ham FlO medium sup- 
plemented with 10% fetal calf serum (Gibco), at 
37”C, in 5% CO2 humidified atmosphere. Ex- 
periments were performed on confluent cells. 
2.2. Degradation of exogenous phingomyelin 
The ‘in situ’ method in [7] was used. [choline- 
methyl-‘4C]Sphingomyelin (NEN, 44 mCi/mmol) 
was incubated overnight (17 h) with cells either in 
Ham FlO medium containing 10% fetal calf serum 
(WM), or in medium with 10% lipoprotein- 
deficient serum (LDM). The lipid was introduced 
in ethanolic solution (final ethanol concentration 
0.2%). The specific activity was 0.1 ,Ki/ml. Final 
concentration was about 2.5 nmol/ml for labeled 
SM, and about 12-15 nmol/ml for unlabeled SM. 
After incubation, the cells were washed 4 times 
with phosphate-buffered solution, and then 
harvested with a rubber policeman. Lipid analyses 
were performed by thin-layer chromatography on 
silica gel plates after direct application of an ali- 
quot of the cell suspension as in [8]. Plates were 
developed in chloroform/methanol/water (65 : 25 : 
4, v/v), and the radioactive spots located by auto- 
radiography or with a radiochromatogram reader 
(Chromelec 101, Numelec-France). Spots were 
then cut out, and the radioactivity measured by 
liquid scintillation in an Intertechnique-spec- 
trometer. Protein determination was performed on 
aliquots of the cell suspension as in [9]. The uptake 
of SM is expressed in pmol/mg cellular protein. 
The in situ degradation was evaluated by the per- 
centage of undegraded SM recovered in the cells 
(i.e., the ratio of the radioactivity recovered in the 
SM spot over the total radioactivity recovered in 
the cells). Under these experimental conditions, as 
we previously described [7], the degradation of 
exogenous SM is mainly achieved by lysosomal 
sphingomyelinase, and the phosphorylcholine thus 
produced is rapidly reincorporated into phosphati- 
dylcholine (PC) in normal fibroblasts. The lipidic 
radioactivity was recovered in SM and PC only. 
The radioactivity recovered at the starting point 
(free bases: choline and/or phosphorylcholine) 
was always less than 5% of the total radioactivity 
found on plates. 
2.3. Sphingomyelinase measurements 
Sphingomyelinase activity was measured on ali- 
quots of cell suspension as in [lo]. The activity is 
Table 1 
Sphingomyelin uptake and degradation by cultured fibroblasts from controls and patients with 
familial hypercholesterolemia, in whole medium or in lipoprotein-deficient medium 
Strain 
In whole medium 
Controls 
GM 283 (hete.) 
GM 376 (hete.) 
GM 2000 (homo.) 
GM 701 (homo.) 
GM 488 (homo.) 
No. of SM uptake 
experiments (pmol/mg) 
6 886 (598-l 180) 
2 586 (481-671) 
2 532 (485-579) 
4 233 (129-354) 
2 308 (254-362) 
2 189 (147-231) 
Undegraded SM 
0.22 (0.14-0.30) 
0.33 (0.30-0.36) 
0.36 (0.31-0.41) 
0.80 (0.73-0.85) 
0.83 (0.78-0.88) 
0.87 (0.84-0.90) 
In lipoprotein- 
deficient medium 
Controls 8 1298 (768-1657) 0.27 (0.16-0.35) 
GM 2000 (homo.) 4 321 (264-369) 0.81 (0.76-0.84) 
GM 701 (homo.) 4 410 (360-492) 0.87 (0.82-0.90) 
Undegraded SM is the ratio of the radioactivity recovered in SM over the total radioactivity 
recovered in the cells. [choline-melhyl-14C]Sphingomyelin (44 mCi/mmol), was incubated overnight 
with cells in Ham FlO medium supplemented either with 10% fetal calf serum, or 10% lipoprotein- 
deficient serum. SM was introduced in ethanolic solution (ethanol, 0.2%; SM 0.1 &i/ml). Range 
in brackets 
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expressed in nmol/h per mg cellular protein 
(triplicates). 
3. RESULTS 
It can be seen in table 1 that in the presence of 
whole medium (WM), the percentage of undegrad- 
ed SM was 0.15-0.30 in controls, increased about 
1.5fold in heterozygotes, and increased 4-fold in 
homozygotes. The SM uptake by cells was reduced 
30-40% in heterozygotes, and 60-75% in 
homozygotes, compared to controls. 
From these results, it could be supposed that SM 
uptake by normal cells in WM is mainly achieved 
by way of lipoproteins, especially LDL, and that 
the LDL-receptor deficiency in FH resulted in a 
marked decrease in SM uptake. In this interpreta- 
tion, the decrease of exogenous SM degradation in 
FH fibroblasts could be explained if receptor- 
mediated endocytosis, which results in a more 
direct access of LDL-SM to lysosomes, is de- 
pressed in these cells. A possible deficiency in 
sphingomyelinase activity is ruled out by the 
results presented in table 2, which shows a large 
overlap between controls and FH cells. 
To check this possibility, we repeated the ex- 
periments in LDM. It can be clearly seen in table 
1 that: 
dP* 
& 
1 
Fig. 1. Degradation of exogenous sphingomyelin by 
cultured fibroblasts from control (l), GM 2000 (2), and 
GM 701 (3), in lipoprotein-deficient medium. Each 
sample in duplicate. 
(ii) The differences in exogenous SM degrada- 
tion between controls and FH cells observed in 
WM were also found in LDM. This is also clearly 
illustrated in fig. 1. 
(i) The SM uptake by controls was not reduced 
but rather increased in LDM as compared to WM. 
This suggests that there are other ways for SM 
delivery to cells than by lipoproteins. 
Thus, our first hypothesis which cannot explain 
such results must be ruled out. The decrease in ex- 
ogenous SM degradation in HF does not appear to 
be directly related to the LDL receptor deficiency 
of FH cells, but rather to an as yet unknown altera- 
tion of SM metabolism in these cells. 
Table 2 4. DISCUSSION 
Sphingomyelinase activity, measured in vitro on cell 
homogenates from controls and patients with familial 
hypercholesterolemia 
Strain Sphingomyelinase 
activity (nmol/h 
per mg protein) 
Range 
Controls 89.9 72.3-103.7 
Heterozygotes 
GM 283 81.4 73.2-97.8 
GM 376 84.5 71.0-94.6 
Homozygotes 
GM 2000 79.8 68.6-91.9 
GM 701 83.4 74.0-95.2 
Measurements were performed in 0.2 M acetate buffer 
(pH 4.5) containing 0.1% Triton X-100 
Under our experimental conditions the degrada- 
tion of exogenous SM appears to be mainly achiev- 
ed by way of the lysosomal sphingomyelinase. 
Authors in [l l] and [12], using slightly different 
experimental conditions, obtained similar results, 
but they also demonstrated the involvement of a 
membrane phosphocholine transferase, which 
catabolizes about lo-15% of the exogenous SM 
[ 121. For a long incubation time (3-4 days) this 
results in significant recovery of the SM choline 
moiety into PC, even in lysosomal sphingomyelin- 
ase-deficient cells (Niemann-Pick disease, type A). 
In our experimental system (17 h incubation time, 
and lower amounts of SM with higher specific 
radioactivity), we were unable to detect a signif- 
icant contribution of non-lysosomal processes in 
2 3 
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the exogenous SM degradation [7]. 
It can also be seen in fig.1 that the radioactive 
material at the starting point of the chromato- 
grams (free bases: choline and/or phosphorylcho- 
line) was almost negligible, less than 5% of the 
total radioactivity recovered on plates, in FH as 
well as in controls. Moreover, [14C]choline incor- 
poration into PC was not significantly reduced in 
FH cells, which excludes a major impairment of 
PC synthesis (not shown). These results strongly 
suggest that the phenomenon described here is 
truly related to a decrease of SM degradation in 
FH cells. As sphingomyelinase activity measured 
in vitro was not significantly reduced, it can be 
supposed that it is the access of exogenous SM to 
the lysosomal compartment which is impaired in 
FH cells. 
Several hypotheses could be considered to ex- 
plain the impairment of the exogenous SM 
degradation observed in FH cells. We suggested 
[2-41 that the strong physical interactions which 
exist between SM and cholesterol [13] could result 
in reciprocal alterations of their metabolisms in 
some pathological situations: in Niemann-Pick 
disease, the metabolic basis is well identified (in 
types A and B) as a deficiency in lysosomal 
sphingomyelinase activity, but cholesterol ac- 
cumulation is often as important as SM accumula- 
tion. In atherosclerotic lesions [14] and in aging 
[15], the increase in the intracellular content of 
cholesterol is often accompanied by a selective in- 
crease in SM without any sphingomyelinase defi- 
ciency when measured in vitro by conventional 
methods. The experiments described in [l] also 
showed that overloading cells with SM resulted in 
lowered LDL internalization and increased 
cholesterol synthesis. From these results, a first 
hypothesis is that alterations of cholesterol 
metabolism which take place in FH cells 116,171 
could result in alterations of SM degradation. No 
increase in intracellular cholesterol content has 
been described in FH cells, but a marked increase 
in cholesterol synthesis is well documented 
[6,16,17]. It is possible that the endogenous and 
exogenous pools of cholesterol are differently 
localized in the cell, and interact differently with 
SM. 
Another hypothesis is that as yet unknown ab- 
normalities in the membrane structure or in 
lysosomal function may exist in FH cells, which 
162 
could impair exogenous SM access to 
sphingomyelinase. Authors in [ 181 have described 
alterations of glycolipid levels and metabolism in 
FH fibroblasts. They found a 5-fold increase in 
SM content in homozygotes compared to normal, 
and concluded that alterations of the cell surface 
could be involved, in addition to the LDL receptor 
deficiency, in the accelerated atherosclerosis in 
FH. Our observations confirm impairment of SM 
metabolism in FH. It could be supposed that mem- 
brane alteration in FH results in lowered SM turn- 
over, and thus, during the time of the experiment, 
in an apparent decrease in exogenous SM degrada- 
tion by the cells. Experiments are now being per- 
formed to study the turnover of the main 
phospholipids (especially SM) in FH compared to 
controls. 
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